Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the only DLBCL MRD ...

UPPSALA, SE / ACCESS Newswire / March 13, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Quarterly sales doubled, expanding market potential exponentiallySEK tQ3 24/25Q3 ...

"CLIA registration represents a significant step forward for ... Specializing in genomic, proteomic, immunoassay, and cell-based assay solutions, the company serves biopharmaceutical innovators with ...

CLIA is composed of 25 of the major cruise lines serving North America. It is an organization that operates pursuant to an agreement filed with the Federal Maritime Commission under the Shipping Act ...

According to Precedence Research, the global Immunoassay market size was evaluated at USD 35.57 billion in 2024 and is expected to hit over USD 56.2 billion by 2034 with a CAGR of 4.68 % from 2025 to ...

The company’s CLIA-certified lab in Irvine ... “One of the key components of the test is a protease turnover assay for an enzyme that is atypically found in the pancreas, thus providing biological ...

School of Chemistry, Guangzhou Key Laboratory of Analytical Chemistry for Biomedicine, South China Normal University, Guangzhou 510006, Guangdong, P. R. China ...

CLIA denotes chemiluminescence immunoassay, ELISA enzyme-linked immunosorbent assay, HIT heparin-induced thrombocytopenia, MGTS monoclonal gammopathy of thrombotic significance, OD optical density ...

The hospitals segment contributed the highest market share in 2024. Market Overview and Industry Potential The chemiluminescence immunoassay (CLIA) is one of the widely used immunological assays to ...

Roche announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver for its cobas liat sexually transmitted ...